Acurx Pharmaceuticals Valuation Multiples

Acurx Pharmaceuticals Overview

About Acurx Pharmaceuticals

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company’s segment consists of the development of clinical and preclinical product candidates for the development of the Company’s proprietary new therapies.

Founded

2017

HQ

Employees

4

Website

acurxpharma.com

Sectors

BiopharmaceuticalsBioTech

Financials (LTM)

Revenue: —

EBITDA: ($8M)

Market Cap

$7M

Valuation Multiples

Multiples.vc

Start free trial

Acurx Pharmaceuticals Financials

Acurx Pharmaceuticals reported last 12-month revenue of — and negative EBITDA of ($8M).

In the same LTM period, Acurx Pharmaceuticals generated — in gross profit, ($8M) in EBITDA losses, and had net loss of ($8M).

Acurx Pharmaceuticals P&L

In the most recent fiscal year, Acurx Pharmaceuticals reported revenue of — and EBITDA of ($8M).

Acurx Pharmaceuticals expects next 12-month revenue of XXX and NTM EBITDA of XXX

Acurx Pharmaceuticals Stock Performance

Acurx Pharmaceuticals has current market cap of $7M.

Acurx Pharmaceuticals' stock price is $2.61.

Acurx Pharmaceuticals Valuation Multiples

Acurx Pharmaceuticals trades at 0.0x EV/EBITDA.

Acurx Pharmaceuticals Financial Valuation Multiples

As of April 12, 2026, Acurx Pharmaceuticals has market cap of $7M.

Equity research analysts estimate Acurx Pharmaceuticals' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Acurx Pharmaceuticals has a P/E ratio of (0.9x).

Acurx Pharmaceuticals Margins & Growth Rates

Acurx Pharmaceuticals' revenue in the last fiscal year grew by —.

Acurx Pharmaceuticals' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $2.0M for the same period.

Acurx Pharmaceuticals Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Acurx Pharmaceuticals M&A Activity

Acurx Pharmaceuticals acquired XXX companies to date.

Last acquisition by Acurx Pharmaceuticals was on XXXXXXXX, XXXXX. Acurx Pharmaceuticals acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Acurx Pharmaceuticals Investment Activity

Acurx Pharmaceuticals invested in XXX companies to date.

Acurx Pharmaceuticals made its latest investment on XXXXXXXX, XXXXX. Acurx Pharmaceuticals invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).